Blog

T cells

Building CGT’s Clinical Trial Potential: PRA’s Partnership with Cell and Gene Therapy Supply Chain Software Leader Vineti

Key Highlights: PRA’s partnership with Vineti will optimize clinical trial delivery, clinical study operations and data management, and commercialization readiness…

Read More
May 30, 2019

When the patient is the product — some key challenges in cell and gene therapies

In personalized therapies — cell therapies, gene therapies, and neoantigen therapies — a patient is not just the recipient of...

May 22, 2019

Cell and gene therapy standards need you!

One week to go! In the next seven days, those of us working in cell and gene therapy have a...

May 15, 2019

Supply chain management readiness, Part 2: operational ecosystem

(Note: this post is the second part of a four-part series on supply chain planning for personalized therapies such as...

May 9, 2019

Cell and gene therapy news: some recent highlights

Things keep moving fast in the world of cell and gene therapy. Here are a few of the recent developments...

May 2, 2019

Commercial lessons for clinical-phase success, Part I: it all starts with collaboration

In early-phase clinical research, it’s common to think that your science resides within your lab. But when it comes to...

April 30, 2019

Q1 update from Vineti

As 2019 shapes up to be yet another landmark year for advanced therapies, Vineti is hard at work on our...

April 24, 2019

Supply chain management readiness, Part 1: strategy

There are many critical decisions to be made when moving a large-molecule biologic out of the lab into human trials....

April 23, 2019

Cell therapy labels that work — pointers to keep your patient and your product in sync

In cell therapy, smarter labeling means greater safety and speed. If you’re a cell therapy developer, you have a make-or-break...

April 23, 2019

Setting standards — three essential starting points

Welcome to the Vineti blog! This is our first post, and we’re looking forward to sharing insights, perspectives and company updates here....